Introducing BCOP Sprint
NEW! Timely BCOP Learning with Your Time In Mind
Sometimes all you have is 30 minutes to spare. With BCOP Sprint, that's all the time you need.
HOPA introduces BCOP Sprint, new education programming where you can earn BCOP CEs and take a deep dive into the latest developments in hem/onc pharmacy – all in just 30 minutes. Throughout the year, BCOP Sprint's 30-minute sessions will alternate between hyper-specialized and late-breaking hematology and solid malignancy topics, "drilling down" to real-time information.
BCOP Sprint 2026 Session 2
"Cancer Therapy Considerations in Transgender and Gender Diverse Patients Receiving Gender Affirming Hormonal Therapy"
- When: Thursday, September 10, 2026, at 11 a.m. CT via Zoom
- Cost: $20 for HOPA members, $26 for non-members
- BCOP Credits: 0.5
Course Description
Join us as we embark on an interview-style conversation examining cancer therapy dosing considerations in transgender and gender diverse patients receiving continuous gender affirming hormonal therapy (GAHT). This discussion will include real world examples and clinical pearls to provide both clinical and cultural context for oncology pharmacists.
Learning Objectives
- Describe laboratory value changes that can occur while patients are receiving continuous gender affirming hormonal therapy (GAHT)
- Apply appropriate calculations for dosing antineoplastic agents in transgender or gender diverse patients (TGD)
There will be 0.5 ACPE and BCOP credits available for this session.
Presenters
Christy S. Harris, PharmD, BCOP, FHOPA, is an Associate Professor of Pharmacy Practice at Massachusetts College of Pharmacy & Health Sciences in Boston with a practice site at Dana-Farber Cancer Institute. Dr. Harris is a graduate of the University of Tennessee where she received her Bachelor of Science and Doctor of Pharmacy degrees. She completed a Clinical Pharmacy residency at the University of Tennessee Medical Center in Knoxville and an Oncology Pharmacy residency at the Medical University of South Carolina in Charleston. She is board certified in Oncology and is a Fellow of the Hematology/Oncology Pharmacy Association. She teaches oncology subjects to pharmacy students in the classroom and caring for the patient with cancer in the clinical setting. At her practice site, she works with providers within the Center for Soft Tissue and Bone Sarcomas and follows patients treated in the Integrative Medicine clinic, assessing supplements for safety during cancer therapy. Other interests in her practice include early-phrase clinical trials, clinical research, and the Adolescent and Young Adult population.
Dr. Leiva (pronouns he/him) is a Board Certified Oncology Pharmacist and an Advanced Practice Pharmacist and educator. Dr. Leiva received his PharmD at Loma Linda University School of Pharmacy in 2010. Prior to pharmacy school, Dr. Leiva completed a B.S. in Microbiology and was an NIH Fellow in the RISE program while pursuing an M.S. in Microbiology. In addition to practicing in several states, he has taught at pharmacy schools on both coasts. Dr. Leiva is a preceptor to pharmacy students, residents, and fellows. Dr. Leiva serves his community as an intermittent Federal Disaster Response Official Pharmacist for the Department of Health and Human Services, where he may be deployed to local, regional, national, and international disasters. Most recently, he was deployed for Hurricane Helene and the So Cal Fires. Dr. Leiva is an Associate Professor of Pharmacy Practice at West Coast University School of Pharmacy.
